The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
In Vivo Pharmacodynamic Activity of Daptomycin
Open accessAbstract
Daptomycin is a lipopeptide antibiotic with activity against a wide range of gram-positive bacteria. We used the neutropenic murine thigh model to characterize the pharmacodynamics of daptomycin. ICR/Swiss mice were rendered neutropenic with cyclophosphamide; and the thigh muscles of the mice were infected with strains of Staphylococcus aureus , Streptococcus pneumoniae , and Enterococcus faecium . Animals were treated by subcutaneous injection of daptomycin at doses of 0.20 to 400 mg/kg of body weight/day divided into one, two, four, or eight doses over 24 h. Daptomycin exhibited linear pharmacokinetics, with an area under the concentration-time curve (AUC) from time zero to infinity/dose of 9.4 and a half-life of 0.9 to 1.4 h. The level of protein binding was 90%. Free daptomycin exhibited concentration-dependent killing and produced in vivo postantibiotic effects (PAEs) of 4.8 to 10.8 h. Nonlinear regression analysis was used to determine which pharmacokinetic (PK) or pharmacodynamic (PD) parameter was important for efficacy by using free drug concentrations. The peak concentration/MIC (peak/MIC) ratio and 24-h AUC/MIC ratio were the PK and PD parameters that best correlated with in vivo efficacy ( R 2 = 83 to 87% for peak/MIC and R 2 = 86% for the AUC/MIC ratio, whereas R 2 = 47 to 50% for the time that the concentration was greater than the MIC) against standard strains of S. aureus and S. pneumoniae . The peak/MIC ratios required for a bacteriostatic effect ranged from 12 to 36 for S. pneumoniae , 59 to 94 for S. aureus , and 0.14 to 0.25 for E. faecium . The AUC/MIC ratios needed for a bacteriostatic effect ranged from 75 to 237 for S. pneumoniae , 388 to 537 for S. aureus , and 0.94 to 1.67 for E. faecium . The free daptomycin concentrations needed to average from one to two times the MIC over 24 h to produce a bacteriostatic effect and two to four times the MIC over 24 h to produce greater than 99% killing. The long PAE and potent bactericidal activity make daptomycin an attractive option for the treatment of infections caused by gram-positive bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Self-citationIn Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic Mice
Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J., & Craig, W. A. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.2.287 · Cited by 259
Self-citationOnce-Daily Dosing in Dogs Optimizes Daptomycin Safety
Oleson, F. B., Berman, C. L., Kirkpatrick, J. B., Regan, K. S., Lai, J.-J., & Tally, F. P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2948-2953.2000 · Cited by 196
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., & Moellering, R. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.532 · Cited by 173
Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection
Louie, A., Kaw, P., Liu, W., Jumbe, N., Miller, M. H., & Drusano, G. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.845-851.2001 · Cited by 172 · cited 2×
“aureus in the neutropenic murine thigh model suggested that the AUC/MIC ratio was the most important PD parameter for daptomycin (17).”
BackgroundBarry, A. L., FUCHS, P. C., & Brown, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1919-1922.2001 · Cited by 158
Woodworth, J. R., Nyhart, E. H., Brier, G. L., Wolny, J. D., & Black, H. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.318 · Cited by 155
Hanberger, H., Nilsson, L. E., Maller, R. K., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1710 · Cited by 139
Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus
Flandrois, J., Fardel, G., & Carret, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.454 · Cited by 48
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci
Andrew, J. H., Wale, M. C. J., Wale, L. J., et al. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.2.213 · Cited by 40
Therapeutic Update on Glycopeptide and Lipopeptide Antibiotics
Rotschafer, J. C., Garrison, M. W., & Rodvold, K. A. (1988) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1988.tb04076.x · Cited by 13
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis
Coudron, P. E., Johnston, J. L., & Archer, G. L. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.4.505 · Cited by 13
Cited by
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Hanley, M. J., Abernethy, D. R., & Greenblatt, D. J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318100-000000000-00000 · Cited by 773
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541
“pneumoniae, including skin and soft tissue (thigh) infections [10], meningitis [11], and endocarditis [12], but has specifically failed in a simple model of BAP (table 1).”
BackgroundBactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French, G. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl393 · Cited by 441
Metadata
- Authors
- Safdar, N., Andes, D., & Craig, W. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-01
- Volume
- 48
- Issue
- 1
- Pages
- 63-68
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1974903759
- Cited by
- 370
- References
- 12
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.